Researchers find that several genetic disorders, including MUC1 kidney disease, may share a novel molecular mechanism—and identify a promising therapeutic lead
Coinciding with the second anniversary of the breakthrough patient-driven research movement, this first of many data releases aims to accelerate progress in metastatic breast cancer research